More and more healthy women and men are found to have thyroid nodules. What are they? And should you be worried about them?
As access to health care increases, there’s also a danger of getting too much of it.
Doctors don’t ‘check you for everything’, but are guided by what you personally would benefit from, based on your age and individual history.
With more than 850 changes to Medicare on the cards, the system needs time to adjust. Hasty implementation may mean patients face higher gap fees.
How do you know if your child’s behaviour is normal or a sign of ADHD? The answer is not so clear cut. And now we have the evidence to show the consequences.
In our new study, we’ve found the majority of news stories are failing to cover potential downsides of early detection tests. This could be perpetuating the problem of overdiagnosis.
The way most dentists in Australia are paid encourages over-servicing. So how do we know the treatment your dentist recommends is actually necessary?
The pandemic’s dramatic drop in health-care use is both a crisis of unmet need and an opportunity to reduce the unneeded.
A new study finds no evidence of diagnostic inflation in the last four editions of the DSM.
Just under one in six Australian women have PCOS but some are being diagnosed when they don’t meet the criteria.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
Prominent GP and former MP Kerryn Phelps has weighed into the doctor-pharmacist turf war, saying pharmacists shouldn’t prescribe because of their financial interests. But the evidence says otherwise.
3D mammography is becoming more widely available, but is it superior to the traditional 2D technology for breast cancer detection? The answer isn’t clear-cut.
It seems like an easy question, until you take a closer look. Then things get messy.
The threshold for diagnosing common conditions such as high blood pressure, chronic kidney disease and gestational diabetes have all lowered in recent years. But for whose benefit?
Sarah and Donna are 26 weeks pregnant and have the same blood sugar levels. But while Donna is diagnosed with gestational diabetes, Sarah is spared from the label. It comes down to where she lives.
New tests may mean more people are diagnosed, but that doesn’t mean they’ll be helped by the label or the treatment. Here are five markers that overdiagnosis may be occuring.
Labelling very low-risk conditions as cancers can cause unnecessary anxiety and lead to overtreatment.
Unfortunately, there is no net benefit-ometer for breast cancer screening.